Levodopa in parkinson's disease--Australian collaborative trial.
D000203:Activities of Daily Living; D000328:Adult; D000367:Age Factors; D000368:Aged; D001315:Australia; D001853:Bone Marrow / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004185:Disability Evaluation; D004562:Electrocardiography; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007360:Intelligence; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D009325:Nausea / Q000517:prevention & control; D010300:Parkinson Disease / Q000188:drug therapy* / Q000601:surgery; D013788:Thalamus / Q000601:surgery; D014839:Vomiting / Q000517:prevention & control
D004295:Dihydroxyphenylalanine